Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias
Clinical trial NCT02041299 · TERMINATED
Trial details
- NCT number
- NCT02041299
- Sponsor
- ApoPharma
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-17
- Primary completion
- 2019-04-20
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.